The P35 protein is encoded by gene XXXV in the PRD1 genome. The gene has been extensively studied through various mutational analyses, including nonsense, missense, and insertion mutations . These studies have provided valuable insights into the functional domains of the protein and their contributions to host cell lysis.
Table 1: Key Molecular Characteristics of PRD1 P35 Protein
| Feature | Description |
|---|---|
| Protein Name | P35 (XXXV) |
| Gene | XXXV |
| UniProt ID | Q3T4L9 |
| Synonyms | XXXV; Holin; Protein P35 |
| Molecular Weight | 12.8 kDa |
| Amino Acid Length | 117 amino acids |
| Protein Class | Class I lambdoid-type holin |
| Key Functional Region | Charged C-terminus |
The P35 protein serves as a critical component in the PRD1 phage infection process, specifically in the final stages of viral reproduction where it facilitates host cell lysis.
P35 functions as a holin protein, a class of phage-encoded membrane proteins that create pores in the host cell's cytoplasmic membrane . These pores allow endolysins (peptidoglycan-degrading enzymes) to access the bacterial cell wall, ultimately leading to cell lysis and release of newly assembled viral particles .
Research has demonstrated that P35 is essential for the membrane permeabilization step in host cell lysis . Without functional P35, the phage cannot efficiently release its progeny from the infected host cell, severely limiting its reproductive capabilities.
PRD1 employs a two-component lysis system consisting of:
P35 (holin) - Creates membrane pores
P15 (endolysin) - Degrades peptidoglycan
This system operates in a coordinated manner, with P35-created membrane permeabilization preceding the activity of P15, which is a soluble β-1,4-N-acetylmuramidase that effectively degrades the peptidoglycan layer of the gram-negative bacterial cell wall . Together, these two proteins accomplish the complete lysis of the host cell.
Studies monitoring ion fluxes and ATP content in PRD1-infected cells have revealed the sequence of physiological changes that occur during the lysis process . The earliest indicator of impending cell lysis is a decrease in intracellular ATP levels, followed by leakage of potassium ions . This suggests that P35-mediated membrane permeabilization disrupts cellular energetics before complete structural breakdown occurs.
Extensive research has been conducted to understand the precise mechanism and regulation of P35 activity in the PRD1 lytic cycle.
Multiple mutational studies have been conducted on gene XXXV to understand structure-function relationships in the P35 protein . These studies have revealed that:
The charged amino acids at the C-terminus of P35 are critical for regulating the timing of host cell lysis
Various nonsense, missense, and insertion mutations in gene XXXV have been analyzed, providing insights into essential regions of the protein
Defects in PRD1 gene XXXV can be functionally complemented by the presence of gene S from bacteriophage lambda, demonstrating functional similarity between these holin proteins
A notable characteristic of PRD1-infected cells is their susceptibility to premature lysis upon addition of metabolic inhibitors such as cyanide . This phenomenon has provided valuable insights into the energy-dependent regulation of P35 activity:
The addition of cyanide (which blocks respiration by inhibiting cytochrome oxidase) to PRD1-infected cells triggers premature lysis
This effect supports the existence of a highly regulated two-component lysis system in PRD1
Arsenate has been found to be particularly effective in triggering premature lysis in PRD1-infected cells
These findings suggest that P35 activity is tightly regulated by cellular energetics, with energy depletion serving as a trigger for P35-mediated membrane permeabilization.
Recent research has identified two additional lysis-related genes in PRD1: XXXVI and XXXVII, which encode proteins P36 and P37, respectively . These proteins have been characterized as accessory lysis proteins functionally analogous to the Rz/Rz1 proteins of bacteriophage λ . While distinct from P35, these proteins operate in conjunction with the holin-endolysin system to ensure efficient host cell disruption under various environmental conditions .
Recombinant full-length Enterobacteria phage PRD1 Protein P35 (XXXV) is produced using standardized expression systems:
The full-length protein (amino acids 1-117) is expressed in E. coli expression systems
The recombinant protein typically includes an N-terminal His-tag to facilitate purification
The expressed protein maintains the complete amino acid sequence of the native P35 protein
The study of P35 protein has contributed significantly to our understanding of viral lysis mechanisms and has potential applications in various fields.
P35 has served as an important model protein for understanding the general principles of phage-mediated bacterial lysis:
Its function as a holin protein exemplifies a common mechanism used by many bacteriophages to accomplish host cell lysis
The well-characterized nature of PRD1 infection makes P35 an excellent model for studying the regulated timing of viral lysis
The interchangeability of P35 with the lambda S protein demonstrates evolutionary conservation of holin function across different phage families
Studies involving P35 have contributed to our understanding of the evolutionary relationships between phages and their bacterial hosts:
PRD1 infects gram-negative bacteria harboring conjugative IncP plasmids such as RP4 and pKJK5
The plasmid-dependent nature of PRD1 infection represents an interesting evolutionary strategy, allowing the phage to target bacteria across different taxonomic groups that share conjugative plasmids
Understanding P35 function provides insights into how phages can exploit specific bacterial vulnerabilities
The lytic properties of P35 suggest potential applications in biotechnology and medicine:
As a model for the development of novel antimicrobial agents targeting bacterial membranes
In phage therapy applications, where understanding lysis mechanisms is crucial for therapeutic efficacy
For controlled lysis of bacterial cells in biotechnological processes where gentle and regulated cell disruption is required
KEGG: vg:5729504
PRD1 Protein P35 is a holin protein that functions as part of a two-component lysis system in bacteriophage PRD1. Holins are phage-induced integral membrane proteins that regulate the access of lytic enzymes to the host cell peptidoglycan at the time of progeny virus release. P35 specifically forms membrane pores that allow the phage endolysin (protein P15) to reach the peptidoglycan layer, causing host cell lysis . The protein works in concert with the P15 endolysin, which is a soluble β-1,4-N-acetylmuramidase that effectively degrades the peptidoglycan of the gram-negative bacterial cell wall .
The PRD1 holin (P35) shares functional similarities with the lambda phage holin (gene S product) despite limited sequence homology. Evidence for this functional conservation comes from complementation studies where the defect in PRD1 gene XXXV can be corrected by the presence of gene S of lambda phage . Like other class I holins, P35 likely forms large pores in the cytoplasmic membrane, allowing the passive diffusion of endolysin to its substrate in the cell wall. The PRD1 lysis system follows the typical two-component architecture (holin-endolysin) observed in many double-stranded DNA phages, but represents a system specific to phages infecting gram-negative bacteria with a conjugative IncP plasmid .
Several complementary techniques have been employed to identify and characterize PRD1 Protein P35:
Genetic approaches: Isolation of nonsense mutants and analysis of complementation groups to identify gene XXXV
Cloning and sequencing: Cloning gene XXXV into expression vectors and determining its sequence
Mutational analysis: Generation of nonsense, missense, and insertion mutations to study protein function
Complementation studies: Testing functional interchangeability with other holin proteins (e.g., lambda S gene)
Physiological measurements: Monitoring ion fluxes (K+ efflux), membrane potential (using TPP+), and cellular ATP levels to track lysis events
Premature lysis induction: Using metabolic inhibitors like cyanide and arsenate to trigger early lysis and study holin function
These approaches collectively established P35 as a bona fide holin protein and elucidated its role in the PRD1 lysis pathway.
Recombinant PRD1 Protein P35 can be expressed in E. coli using appropriate expression vectors. Based on available information:
Expression system: The full-length protein (amino acids 1-117) can be expressed with an N-terminal His-tag in E. coli .
Vector selection: High-level expression vectors like pET32a have been successfully used for P35 expression .
Host strain considerations: Expression in E. coli strains containing pLysS may help reduce basal expression levels and toxicity .
Purification approach: His-tagged P35 can be purified using affinity chromatography.
Storage recommendations: The purified protein should be stored in Tris/PBS-based buffer (pH 8.0) with 6% trehalose. For long-term storage, aliquoting with 5-50% glycerol and storage at -20°C/-80°C is recommended .
Stability considerations: Repeated freeze-thaw cycles should be avoided; working aliquots can be stored at 4°C for up to one week .
Various mutations in PRD1 Protein P35 have revealed critical insights about structure-function relationships:
C-terminal charged residues: Mutations affecting the charged amino acids at the C-terminus have been shown to alter the timing of host cell lysis, suggesting this region functions as a molecular clock regulating lysis timing .
Nonsense mutations: Several nonsense mutants (including sus711, sus712, sus714, sus715, sus716, and sus718) have been characterized and mapped to gene XXXV, providing evidence for its essential role in the lysis process .
Insertion mutations: PRD1 insertional mutants (including 13272, 13273, 13284, 13290, 13300, and 13315) generated using Mu in vitro transposition technology have been used to identify genomic regions tolerant to insertion and genes not essential for virus propagation .
Point mutations: Point mutations created through targeted mutagenesis approaches have helped define specific amino acid residues critical for holin function and regulation .
PRD1 holin activity during infection can be monitored through several physiological changes that occur in a specific sequence:
ATP depletion: The earliest detectable indicator of cell lysis is a decrease in intracellular ATP levels .
K+ efflux: Following ATP depletion, leakage of potassium ions from the cell indicates increased cytoplasmic membrane permeability due to holin pore formation .
Membrane depolarization: Changes in membrane potential, monitored using lipophilic cations like tetraphenylphosphonium (TPP+), indicate holin-mediated membrane permeabilization .
Cell lysis: Ultimate rupture of the cell due to endolysin activity, releasing phage progeny .
This sequence of events provides a comprehensive picture of holin-mediated lysis progression and can be used as a framework for studying lysis kinetics in different mutant backgrounds.
The PRD1 two-component lysis system operates through coordinated action of holin (P35) and endolysin (P15):
Initial phase: During phage replication, both holin and endolysin proteins accumulate in the infected cell.
Holin accumulation: P35 integrates into the cytoplasmic membrane but does not immediately form pores, allowing phage assembly to proceed.
Triggering event: At a genetically programmed time, holin proteins oligomerize to form pores in the cytoplasmic membrane, causing membrane depolarization.
Endolysin access: These pores allow the accumulated endolysin (P15) to access the peptidoglycan layer.
Cell wall degradation: P15, a β-1,4-N-acetylmuramidase, degrades the peptidoglycan layer, leading to cell lysis and release of progeny phages .
Premature triggering: This system can be prematurely activated by metabolic inhibitors like cyanide and arsenate, which likely affect the energized state of the membrane .
This coordinated mechanism ensures that lysis occurs at the optimal time for maximum phage production, balancing the need for sufficient progeny production against the benefit of early release.
Several complementary assays can be employed to measure PRD1 holin activity:
Cell viability and lysis assays:
Physiological parameter measurements:
Genetic complementation assays:
Premature lysis induction:
These assays provide multilayered information about holin function, from molecular activity to whole-cell physiological effects.
When studying PRD1 Protein P35 function, several critical controls should be included:
Negative controls:
Positive controls:
Complementation controls:
Expression of wild-type gene XXXV in holin-deficient backgrounds
Cross-complementation with heterologous holins
Technical controls:
Media-only controls for background measurements
Metabolic inhibitor-only treatments to establish direct effects on uninfected cells
Time-matched samples to account for culture aging effects
Including these controls ensures that observed effects can be confidently attributed to PRD1 Protein P35 function rather than experimental artifacts or secondary effects.
When interpreting physiological data from PRD1 holin activity studies, researchers should consider:
Temporal sequence of events:
Magnitude and rate analysis:
The rate of K+ efflux correlates with the rate of holin pore formation
The magnitude of ATP depletion reflects the degree of membrane permeabilization
Comparative analysis:
Compare wild-type PRD1 infection with holin mutants to identify specific P35 effects
Compare effects of different metabolic inhibitors on lysis timing
Integration of multiple parameters:
Correlate ATP levels, ion fluxes, membrane potential, and optical density data
Develop models of the sequence of physiological changes during lysis
Mutation-specific effects:
This integrated approach to data interpretation allows researchers to develop comprehensive models of holin function and regulation.
Structure-function analyses of PRD1 Protein P35 have revealed several key insights:
Functional domains:
Functional similarities:
Mutational effects:
Physiological mechanism:
These insights collectively support a model where PRD1 Protein P35 functions as a precisely regulated membrane-permeabilizing protein with specific structural elements controlling its activation timing.
Several promising approaches could advance our understanding of PRD1 holin structure-function relationships:
High-resolution structural studies:
Cryo-electron microscopy of membrane-embedded P35 oligomers
NMR studies of solubilized protein domains
X-ray crystallography of stabilized protein complexes
Advanced mutagenesis approaches:
Systematic alanine scanning mutagenesis of the full protein
Targeted modification of charged residues at the C-terminus
Creation of chimeric holins combining domains from different phages
Single-molecule techniques:
Patch-clamp electrophysiology to characterize pore conductance
Single-molecule fluorescence to track protein oligomerization
Real-time imaging of membrane permeabilization events
Computational approaches:
Molecular dynamics simulations of membrane insertion and pore formation
Ab initio modeling of three-dimensional structure
Prediction of protein-protein interaction sites
Host-pathogen interaction studies:
Investigation of host factors affecting holin function
Analysis of membrane composition effects on timing and efficiency
These approaches would provide complementary insights into the structural basis of PRD1 holin function and regulation.
Research on PRD1 Protein P35 has implications for several broader bacteriophage applications:
Phage therapy development:
Engineering holins with modified lysis timing could optimize phage therapy efficacy
Understanding lysis mechanisms helps predict phage behavior in therapeutic contexts
Biotechnology applications:
Holins could be engineered as controlled cell lysis tools for recombinant protein release
P35 variants might serve as regulatable membrane permeabilization agents
Synthetic biology:
PRD1 lysis components could be incorporated into synthetic gene circuits requiring timed lysis
The two-component system provides modular parts for synthetic biology applications
Antimicrobial development:
Holin-inspired peptides might serve as novel antimicrobial agents
Understanding holin function could inform strategies to potentiate conventional antibiotics
Fundamental virology:
Comparative studies of diverse holins illuminate evolutionary relationships
Mechanistic insights inform models of phage-host co-evolution
These diverse applications highlight the significance of basic research on phage lysis mechanisms for both fundamental science and applied technologies.
Optimal buffer conditions for maintaining recombinant PRD1 Protein P35 stability include:
| Parameter | Recommended Condition | Notes |
|---|---|---|
| Buffer base | Tris/PBS-based buffer | Maintains physiological compatibility |
| pH | 8.0 | Optimal for protein stability |
| Stabilizing agent | 6% Trehalose | Preserves structure during freeze-thaw |
| Storage additive | 5-50% Glycerol (final) | Prevents freeze damage; 50% is standard |
| Storage temperature | -20°C/-80°C | For long-term storage in aliquots |
| Working storage | 4°C | For up to one week |
| Reconstitution | Deionized sterile water | To concentration of 0.1-1.0 mg/mL |
| Freeze-thaw | Minimize cycles | Repeated freezing and thawing not recommended |
Following these storage recommendations helps maintain the structural integrity and functional activity of recombinant PRD1 Protein P35 .
Several techniques can effectively study PRD1 holin oligomerization and pore formation:
Biochemical approaches:
Cross-linking studies to capture oligomeric states
Blue-native PAGE to analyze protein complexes
Size exclusion chromatography to separate different oligomeric forms
Biophysical techniques:
Fluorescence resonance energy transfer (FRET) to detect protein-protein interactions
Analytical ultracentrifugation to determine oligomer size and shape
Small-angle X-ray scattering for low-resolution structural information
Functional assays:
Liposome permeabilization assays using fluorescent dyes
Planar lipid bilayer electrophysiology to measure pore conductance
Atomic force microscopy to visualize membrane-embedded complexes
Computational approaches:
Molecular dynamics simulations of oligomerization
Protein-protein docking to predict interaction interfaces
Coarse-grained modeling of membrane insertion
Genetic approaches:
Suppressor mutation analysis to identify interacting residues
Split protein complementation assays to detect oligomerization in vivo
These diverse approaches provide complementary information about the molecular mechanisms of PRD1 holin assembly and function.
PRD1 Protein P35 shares functional similarities but has distinct characteristics compared to holins from other bacteriophage families:
| Feature | PRD1 P35 | Lambda S | T4 T | Other Holins |
|---|---|---|---|---|
| Size | 12.8 kDa (117 aa) | ~8-11 kDa (varies by isoform) | 18.5 kDa | Variable |
| Classification | Likely Class I | Class I | Class III | Classes I-III |
| Membrane topology | Multiple TMDs | 3 TMDs | 1 TMD | Variable |
| Dual-start motif | Not reported | Yes (S105/S107) | No | Variable |
| Cross-complementation | Can be complemented by lambda S | Can complement PRD1 | Limited | Phage-specific |
| Regulatory mechanism | C-terminal charged residues | N-terminal dual start | Regulated by T | Variable |
| Pore size | Small molecule passage | Large, >nm | Small | Variable |
Despite these differences, PRD1 P35 maintains the core holin function of timing-regulated membrane permeabilization to allow endolysin access to peptidoglycan . The functional interchangeability with lambda S protein suggests conservation of critical structural elements despite limited sequence homology .
Studies of PRD1 holin provide several insights applicable to other membrane-permeabilizing proteins:
Timing regulation mechanisms:
The role of charged residues in controlling oligomerization timing
The influence of membrane potential on activation
Energy-dependent inhibition of premature pore formation
Pore formation principles:
Stepwise progression from monomers to functional pores
Relationship between protein structure and pore size/selectivity
Role of specific amino acids in determining pore characteristics
Physiological consequences:
Sequence of events following membrane permeabilization (ATP depletion, ion fluxes)
Differential permeability to various cellular components
Interactions between pore-forming proteins and cellular energy state
Structure-function relationships:
Essential domains for membrane integration versus pore formation
Conservation of functional mechanisms despite sequence divergence
Molecular determinants of timing versus pore size